These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 22961748)

  • 61. Low-mass-ion discriminant equation: a new concept for colorectal cancer screening.
    Lee JH; Kim KH; Park JW; Chang HJ; Kim BC; Kim SY; Kim KG; Lee ES; Kim DY; Oh JH; Yoo BC; Kim IH
    Int J Cancer; 2014 Apr; 134(8):1844-53. PubMed ID: 24096867
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Macrophage mannose receptor 1 and S100A9 were identified as serum diagnostic biomarkers for colorectal cancer through a label-free quantitative proteomic analysis.
    Fan NJ; Chen HM; Song W; Zhang ZY; Zhang MD; Feng LY; Gao CF
    Cancer Biomark; 2016; 16(2):235-43. PubMed ID: 26682511
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Screening for potential serum-based proteomic biomarkers for human type 2 diabetes mellitus using MALDI-TOF MS.
    Meng Q; Ge S; Yan W; Li R; Dou J; Wang H; Wang B; Ma Q; Zhou Y; Song M; Yu X; Wang H; Yang X; Liu F; Alzain MA; Yan Y; Zhang L; Wu L; Zhao F; He Y; Guo X; Chen F; Xu W; Garcia M; Menon D; Wang Y; Mu Y; Wang W
    Proteomics Clin Appl; 2017 Mar; 11(3-4):. PubMed ID: 27863080
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Histone-lysine N-methyltransferase SETD7 is a potential serum biomarker for colorectal cancer patients.
    Duan B; Bai J; Qiu J; Wang J; Tong C; Wang X; Miao J; Li Z; Li W; Yang J; Huang C
    EBioMedicine; 2018 Nov; 37():134-143. PubMed ID: 30361067
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Identification of a new protein biomarker for colorectal cancer diagnosis.
    Zhai XH; Yu JK; Yang FQ; Zheng S
    Mol Med Rep; 2012 Aug; 6(2):444-8. PubMed ID: 22614045
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Proteomics, genomics and transcriptomics: their emerging roles in the discovery and validation of colorectal cancer biomarkers.
    Wang K; Huang C; Nice EC
    Expert Rev Proteomics; 2014 Apr; 11(2):179-205. PubMed ID: 24611605
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Identification alpha-2-HS-glycoprotein precursor and tubulin beta chain as serology diagnosis biomarker of colorectal cancer.
    Fan NJ; Kang R; Ge XY; Li M; Liu Y; Chen HM; Gao CF
    Diagn Pathol; 2014 Mar; 9():53. PubMed ID: 24618180
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Proteomics of colorectal cancer: overview of discovery studies and identification of commonly identified cancer-associated proteins and candidate CRC serum markers.
    Jimenez CR; Knol JC; Meijer GA; Fijneman RJ
    J Proteomics; 2010 Sep; 73(10):1873-95. PubMed ID: 20601272
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Profiling of schizophrenia-associated serum peptides by MALDI-TOF-MS.
    Fu Y; Zhou N; Yu Y; Zhang H; Sun Y; Zhang M; Chen X; Wang Y; Yu Q
    J Neural Transm (Vienna); 2020 Jan; 127(1):95-101. PubMed ID: 31786691
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Candidate biomarker verification: Critical examination of a serum protein pattern for human colorectal cancer.
    Albrethsen J; Bøgebo R; Møller CH; Olsen JA; Raskov HH; Gammeltoft S
    Proteomics Clin Appl; 2012 Apr; 6(3-4):182-9. PubMed ID: 22532454
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A Meta-Analysis of Proteomic Blood Markers of Colorectal Cancer.
    Chen X; Sun J; Wang X; Yuan Y; Cai L; Xie Y; Fan Z; Liu K; Jiao X
    Curr Med Chem; 2021; 28(6):1176-1196. PubMed ID: 32338203
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Identification of Regional Lymph Node Involvement of Colorectal Cancer by Serum SELDI Proteomic Patterns.
    Fan NJ; Gao CF; Wang XL
    Gastroenterol Res Pract; 2011; 2011():784967. PubMed ID: 22253617
    [TBL] [Abstract][Full Text] [Related]  

  • 73. High-Throughput Metabolic Pattern Screening Strategy for Early Colorectal and Gastric Cancers Based on Covalent Organic Frameworks-Assisted Laser Desorption/Ionization Mass Spectrometry.
    Yang C; Yu H; Li W; Lin H; Wu H; Deng C
    Anal Chem; 2024 Apr; 96(16):6264-6274. PubMed ID: 38600676
    [TBL] [Abstract][Full Text] [Related]  

  • 74. An integrated approach to the detection of colorectal cancer utilizing proteomics and bioinformatics.
    Yu JK; Chen YD; Zheng S
    World J Gastroenterol; 2004 Nov; 10(21):3127-31. PubMed ID: 15457557
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Proteomic screening of potential N-glycoprotein biomarkers for colorectal cancer by TMT labeling combined with LC-MS/MS.
    Gong Q; Zhang X; Liang A; Huang S; Tian G; Yuan M; Ke Q; Cai Y; Yan B; Wang J; Wang J
    Clin Chim Acta; 2021 Oct; 521():122-130. PubMed ID: 34242638
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Alterations of the Plasma Peptidome Profiling in Colorectal Cancer Progression.
    Bedin C; Crotti S; Ragazzi E; Pucciarelli S; Agatea L; Tasciotti E; Ferrari M; Traldi P; Rizzolio F; Giordano A; Nitti D; Agostini M
    J Cell Physiol; 2016 Apr; 231(4):915-25. PubMed ID: 26379225
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Analysis of the Lipid Profile in Patients with Colorectal Cancer in Advanced Stages.
    de Figueiredo Junior AG; Serafim PVP; de Melo AA; Felipe AV; Lo Turco EG; da Silva IDCG; Forones NM
    Asian Pac J Cancer Prev; 2018 May; 19(5):1287-1293. PubMed ID: 29802561
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Elevated levels of 14-3-3 proteins, serotonin, gamma enolase and pyruvate kinase identified in clinical samples from patients diagnosed with colorectal cancer.
    Dowling P; Hughes DJ; Larkin AM; Meiller J; Henry M; Meleady P; Lynch V; Pardini B; Naccarati A; Levy M; Vodicka P; Neary P; Clynes M
    Clin Chim Acta; 2015 Feb; 441():133-41. PubMed ID: 25540887
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Complement C3f serum levels may predict breast cancer risk in women with gross cystic disease of the breast.
    Profumo A; Mangerini R; Rubagotti A; Romano P; Damonte G; Guglielmini P; Facchiano A; Ferri F; Ricci F; Rocco M; Boccardo F
    J Proteomics; 2013 Jun; 85():44-52. PubMed ID: 23639844
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Endoprotease profiling with double-tagged peptide substrates: a new diagnostic approach in oncology.
    Peccerella T; Lukan N; Hofheinz R; Schadendorf D; Kostrezewa M; Neumaier M; Findeisen P
    Clin Chem; 2010 Feb; 56(2):272-80. PubMed ID: 20110451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.